Imbruvica
Ibrutinib
- Concentración
- 140mg
- Fabricante
- Janssen-Cilag Pharma
- Disponibilidad
- Disponible para obtener
Ibrutinib 140mg — Capsule, 90's Pot
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: Imbruvica by Pharmacyclics · Manufacturer: Janssen-Cilag Pharma. Indication & Dosage: Imbruvica (Ibrutinib), is a prescription medicine used to treat certain cancers such as Mantle cell lymphoma (MCL), Chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma, Marginal zone lymphoma (MZL), Waldenstrom macroglobulinemia, Chronic graft-versus-host (cGVHD) disease. Imbruvica manufactured by Janssen-Cilag Pharma Ltd. in USA. Ibrutinib has to take orally once daily with a glass of water. Side Effects: The most common adverse reactions of Ibrutinib are: Thrombocytopenia , diarrhea , neutropenia, anemia, fatigue , musculoskeletal pain, peripheral edema, upper respiratory tract infection, nausea , bruising, dyspnea, constipation , skin rash, abdominal pain, vomiting, and loss of appetite. The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.
